Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10251921 Compositions comprising bacterial strains

Patent 10251921 was granted and assigned to 4D Pharma Research Limited on April, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

4D Pharma Research Limited

Current Assignee

4D Pharma Research Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10251921

Patent Inventor Names

Seanin McCluskey0

Emma Raftis0

George Grant0

Imke Mulder0

Angela Margaret Patterson0

Date of Patent

April 9, 2019

Patent Application Number

15673270

Date Filed

August 9, 2017

Patent Citations

‌

US Patent 10086023 Compositions comprising bacterial strains

‌

US Patent 10086022 Compositions comprising bacterial strains

‌

US Patent 10046015 Compositions comprising bacterial strains

‌

US Patent 10058574 Compositions comprising bacterial strains

‌

US Patent 10080772 Compositions comprising bacterial strains

‌

US Patent 10086020 Compositions comprising bacterial strains

‌

US Patent 10086021 Compositions comprising bacterial strains

Patent Primary Examiner

‌

Robert A Zeman

Patent abstract

The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10251921 Compositions comprising bacterial strains

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API